Kidney Disease Clinical Trials in Phoenix

Showing 321-340 of 393 trials

Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients

NCT01436500

A study of ifetroban in the treatment of hepatorenal syndrome (HRS) in hospitalized adult patients to assess the safety and pharmacokinetics of 3 days of intravenous ifetroban.

Hepatorenal Syndrome

Cumberland Pharmaceuticals55 participantsStarted Oct 2011

Phoenix, Arizona, United States • La Jolla, California, United States • San Francisco, California, United States +9 more locations

COMPLETEDPhase 2/3< 1 mile

Efficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Patients Receiving a Kidney Transplant

NCT02490202

Safety and efficacy study of SANGUINATE on reduction of delayed graft function (DGF) in patients who will be recipients of a donation after brain death (DBD) donor kidney.

Delayed Function of Renal Transplant

Prolong Pharmaceuticals60 participantsStarted Aug 2015

Phoenix, Arizona, United States • Los Angeles, California, United States • San Diego, California, United States +17 more locations

Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients

Efficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Patients Receiving a Kidney Transplant

Kidney Disease Trials in Other Cities

A Phase 2 Extension of Study GCS-100-CS-4003

Gadobutrol Enhanced MRA of the Renal Arteries

Dialysis Clinical Outcomes Revisited (DCOR) Trial

A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes

Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects

The Drug Induced Renal Injury Consortium

Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant

Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma

Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma

An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney Disease

Delivery of Soluble Ferric Pyrophosphate (SFP) Via the Dialysate to Maintain Iron Balance in Hemodialysis Patients

An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.

Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis

Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC

Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study

Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma

Study of Tolerant Kidney Transplant Recipients

Safety of Gadovist in Renally Impaired Patients

Other Conditions in Phoenix